Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study

BACKGROUND: Currently available treatments for secondary progressive multiple sclerosis(SPMS) have limited efficacy and/or safety concerns. Adipose-mesenchymal derived stem cells(AdMSCs) represent a promising option and can be readily obtained using minimally invasive procedures. PATIENTS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández, Oscar, Izquierdo, Guillermo, Fernández, Victoria, Leyva, Laura, Reyes, Virginia, Guerrero, Miguel, León, Antonio, Arnaiz, Carlos, Navarro, Guillermo, Páramo, Maria Dolores, la Cuesta, Antonio De, Soria, Bernat, Hmadcha, Abdelkrim, Pozo, David, Fernandez-Montesinos, Rafael, Leal, Maria, Ochotorena, Itziar, Gálvez, Patricia, Geniz, Maria Angeles, Barón, Francisco Javier, Mata, Rosario, Medina, Cristina, Caparrós-Escudero, Carlos, Cardesa, Ana, Cuende, Natividad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955528/
https://www.ncbi.nlm.nih.gov/pubmed/29768414
http://dx.doi.org/10.1371/journal.pone.0195891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955528/
https://www.ncbi.nlm.nih.gov/pubmed/29768414
http://dx.doi.org/10.1371/journal.pone.0195891

Ejemplares similares